2026 U.S. Summer Program - 1L Candidates (Patent Development)
DLA Piper
About this role
A 2026 Summer Associate position in DLA Piper’s Patent Development & Strategy group, based in Boston or Palo Alto, offering a tailored 10-week program with in-depth training, pro bono opportunities, and networking. The role is designed for law students interested in intellectual property and who have a background or education in science.
Skills
Qualifications
About DLA Piper
dlapiper.comDLA Piper is a global law firm delivering seamlessly executed legal solutions across 40+ countries. With an agile mindset, deep industry expertise, and a commitment to innovation, we help clients navigate growth, change, and complexity—making global easy.
Recent company news
Bloomberg Law NewsDLA Piper Plans to Ax Verein Structure in Play to Boost Profits
5 hours ago
DLA PiperManaged Services Organizations vs. Alternative Business Structures: Two models for outside investment in law firms
Jan 6, 2026
Law.comDLA Piper Adds 4 More Partners as it Continues Hiring Spree
1 week ago
Law.asiaClyde & Co strengthens insurance practice with DLA Piper hire
2 days ago
ReutersLaw firm DLA Piper must face lawsuit over pregnancy bias, judge rules
Sep 29, 2025
About DLA Piper
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for DLA Piper.
Salary
$55k – $76k
per year
More jobs at DLA Piper
Similar Jobs
2027 2L Patent Prosecution Summer Associate
Stoel Rives LLP
2026 1L Summer Associate (Dual Summer) – Palo Alto
Perkins & Co
2026 1L Patent Litigation Fellowship (Dual Summer)
Perkins & Co
Patent Agent
BAK1005BKH
Patent Prosecution Attorney
North Star Staffing Solutions, Inc.
Senior Counsel, Patent Prosecution
AbbVie